login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
HERON THERAPEUTICS INC (HRTX) Stock News
USA
- NASDAQ:HRTX -
US4277461020
-
Common Stock
1.29
USD
-0.01 (-0.77%)
Last: 10/17/2025, 8:18:36 PM
1.29
USD
0 (0%)
After Hours:
10/17/2025, 8:18:36 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
HRTX Latest News, Press Relases and Analysis
All
Press Releases
2 months ago - By: Heron Therapeutics, Inc.
Heron Therapeutics, Inc. Adopts Tax Benefits Preservation Plan to Protect NOL Assets and Shareholder Value
2 months ago - By: Benzinga
- Mentions:
OPRX
SRTS
BIVI
VREX
...
12 Health Care Stocks Moving In Friday's Intraday Session
6 months ago - By: Benzinga
- Mentions:
ENLT
SSL
ATKR
GPOR
...
Earnings Scheduled For May 6, 2025
6 months ago - By: Zacks Investment Research
- Mentions:
FOX
Best Momentum Stocks to Buy for April 22nd
2 months ago - By: Zacks Investment Research
Heron Therapeutics (HRTX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
2 months ago - By: Zacks Investment Research
- Mentions:
LYRA
Heron Therapeutics (HRTX) Reports Q2 Loss, Misses Revenue Estimates
2 months ago - By: The Motley Fool
Heron (HRTX) Q2 Acute Care Jumps 56%
2 months ago - By: Heron Therapeutics, Inc.
- Mentions:
HTGC
Heron Therapeutics Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity Profile
2 months ago - By: Heron Therapeutics, Inc.
Heron Therapeutics Announces Q2 2025 Financial Results and Highlights Commercial Progress
2 months ago - By: Heron Therapeutics, Inc.
Heron Therapeutics Reschedules Second Quarter 2025 Earnings Release and Conference Call to Friday, August 8, 2025
a year ago - By: Heron Therapeutics, Inc.
U.S. District Court Upholds Validity of CINVANTIĀ® Patents
3 months ago - By: Heron Therapeutics, Inc.
Heron Therapeutics to Report Second Quarter 2025 Financial Results on Monday, August 11, 2025
3 months ago - By: Zacks Investment Research
- Mentions:
CVS
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
6 months ago - By: Zacks Investment Research
Compared to Estimates, Heron Therapeutics (HRTX) Q1 Earnings: A Look at Key Metrics
6 months ago - By: Zacks Investment Research
- Mentions:
STVN
Heron Therapeutics (HRTX) Q1 Earnings and Revenues Top Estimates
6 months ago - By: Heron Therapeutics, Inc.
Heron Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Corporate Updates
6 months ago - By: Heron Therapeutics, Inc.
Heron Therapeutics Announces Settlement with Mylan Related to CINVANTIĀ® and APONVIEĀ® Patent Litigations
6 months ago - By: Zacks Investment Research
- Mentions:
MTD
MASS
AVAH
MTD Q1 Earnings Top Estimates, Sales Decline Y/Y, Shares Rise
6 months ago - By: Zacks Investment Research
- Mentions:
AKBA
Akebia Therapeutics (AKBA) Expected to Beat Earnings Estimates: Should You Buy?
6 months ago - By: Zacks Investment Research
- Mentions:
CORT
Heron Therapeutics (HRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
6 months ago - By: Heron Therapeutics, Inc.
Heron Therapeutics Announces Appointment of Mark Hensley as Chief Operating Officer
6 months ago - By: Yahoo Finance
- Mentions:
PEP
HRTG
MRX
VRTX
...
Tariff turmoil: What P&G, Pepsi and other companies are saying about tariffs
6 months ago - By: Zacks Investment Research
- Mentions:
ESPR
AUPH
PSTV
PYXS
5 Small Drug Stocks to Buy as Tariff-Related Uncertainty Looms
6 months ago - By: Zacks Investment Research
- Mentions:
EXAS
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
6 months ago - By: Heron Therapeutics, Inc.
Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025
6 months ago - By: Zacks Investment Research
- Mentions:
EHC
Are Medical Stocks Lagging Encompass Health (EHC) This Year?
8 months ago - By: Heron Therapeutics, Inc.
Heron Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Updates
8 months ago - By: Heron Therapeutics, Inc.
Heron Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results On Thursday, February 27, 2025
10 months ago - By: Heron Therapeutics, Inc.
Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North Carolina
Please enable JavaScript to continue using this application.